108 related articles for article (PubMed ID: 1229436)
1. [Immunosuppression through alkylating agents: hints on the superiority of 5122 ASTA to cyclophosphamide].
Botzenhardt U; Lemmel EM
Verh Dtsch Ges Inn Med; 1975; 81():1191-3. PubMed ID: 1229436
[No Abstract] [Full Text] [Related]
2. [Effect of cyclophosphamide and other homologous oxazaphosphorine-2-oxides on transplantation-immunologic reactions].
Müller-Ruchholtz W
Arzneimittelforschung; 1974 Aug; 24(8):1160-7. PubMed ID: 4370872
[No Abstract] [Full Text] [Related]
3. [Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)].
Botzenhardt U; Lemmel EM
Arzneimittelforschung; 1974 Aug; 24(8):1167-72. PubMed ID: 4154071
[No Abstract] [Full Text] [Related]
4. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
[No Abstract] [Full Text] [Related]
5. [Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents].
Müller US; Wirth W; Thöne F; Junge-Hülsing G; Hauss WH
Arzneimittelforschung; 1973 Apr; 23(4):487-91. PubMed ID: 4268068
[No Abstract] [Full Text] [Related]
6. Teratogenicity and neonatal toxicity of ifosfamide in mice.
Bus JS; Gibson JE; Reinke DA
Proc Soc Exp Biol Med; 1973 Sep; 143(4):965-70. PubMed ID: 4743716
[No Abstract] [Full Text] [Related]
7. Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride.
Calne RY
Clin Exp Immunol; 1979 Jan; 35(1):1-9. PubMed ID: 371877
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cellular immune reactions by cyclophosphamide analogues ifosfamide and trofosfamide. I. Mixed lymphocyte reaction.
Devlin RG; Schwartz NL; Baronowsky PE; Zygmunt WA
Proc Soc Exp Biol Med; 1974 Feb; 145(2):389-91. PubMed ID: 4273394
[No Abstract] [Full Text] [Related]
9. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
Brock N; Kuhlmann J
Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
[No Abstract] [Full Text] [Related]
10. Immunosuppressive properties of cyclophosphamide analogues.
Harrison EF; Fuquay ME
Proc Soc Exp Biol Med; 1972 Mar; 139(3):957-63. PubMed ID: 5063370
[No Abstract] [Full Text] [Related]
11. Pharmacological immunosuppressive agents.
Salaman JR
Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656
[No Abstract] [Full Text] [Related]
12. Immunosuppression by chemical agents.
Bach JF
Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894
[No Abstract] [Full Text] [Related]
13. [Influence of immunosuppressive agents on immunologic reactivity].
Müller-Ruchholtz W
Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):206-10. PubMed ID: 4626740
[No Abstract] [Full Text] [Related]
14. Immunosuppression by alkylating agents--tolerance induction.
Aisenberg AC
Transplant Proc; 1973 Sep; 5(3):1221-6. PubMed ID: 4580720
[No Abstract] [Full Text] [Related]
15. Cytotoxicity of antitumor agents in a synchronous mammalian cell system.
Bhuyan BK; Fraser TJ
Cancer Chemother Rep; 1974; 58(2):149-55. PubMed ID: 4133836
[No Abstract] [Full Text] [Related]
16. [Sensitivity of the splenic cells of different mouse strains to the antiproliferative action of alkylating compounds].
Pukhal'skiĭ AL; Mezhneva AP; Pevnitskiĭ LA
Biull Eksp Biol Med; 1988 Feb; 105(2):196-8. PubMed ID: 3349150
[TBL] [Abstract][Full Text] [Related]
17. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Kline I
Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
[No Abstract] [Full Text] [Related]
18. Virus induced diabetes and the immune system. I. Suggestion that appearance of diabetes depends on immune reactions.
Jansen FK; Müntefering H; Schmidt WA
Diabetologia; 1977 Sep; 13(5):545-9. PubMed ID: 198323
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppression through 036, 51222 (Asta): induction of immunologic tolerance against sheep erythrocytes].
Botzenhardt U; Ahr W; Lemmel EM
Verh Dtsch Ges Inn Med; 1974; 80():1595-7. PubMed ID: 4454490
[No Abstract] [Full Text] [Related]
20. [Viewpoints on the pharmacological suppression of immunologic reactivity].
Floersheim GL
Schweiz Med Wochenschr; 1975 Oct; 105(43):1373-81. PubMed ID: 766172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
